Group (n) | NC (38) | C (13) | ||||
---|---|---|---|---|---|---|
B | W2 | W12 | B | W2 | W12 | |
ACQ† | 3.43 ± 1.14 | 2.54 ± 1.11a | 2.62 ± 0.75 b | 2.8 ± 1.06 | 1.50 ± 0.76* a | 0.92 ± 0.22* b |
ACT§ | 10 (7 – 14) | 13 (10 – 14) | 13 (12 – 15) | 13 (8 – 16) | 17 (13 -– 20)* a | 21 (19 – 23)* b |
Rescue medication (puff/day) § | 3.1 (1.1 – 5.3) | 2.5 (1.3 – 4.2) a | 2.2 (1.0 – 3.4) b | 2.7 (1.0 – 6.3) | 1.0 (0.2 – 3.0) a | 0.4 (0 – 2.3)* b |
Days free of symptoms (%)§ | 0 (0 – 21) | 7 (0 – 33) | 0 (0 – 33) | 0 (0 – 20) | 42 (20 – 84)* a | 92 (22 – 100)* b |
FVC (%)† | 66.8 ± 17.9 | 76.5 ± 21.3 a | 69.5 ± 20.4 | 68.2 ± 23.3 | 82.3 ± 15.9 a | 83.3 ± 18.5* b |
FEV1 (%)† | 49.8 ± 17.3 | 65.4 ± 22.4a | 55.2 ± 19.3b | 54.8 ± 19.6 | 70.7 ± 18.6 a | 70.0 ± 21.8* b |
FEV1/FVC† | 65 ± 13 | 65 ± 22 | 68 ± 13 | 60 ± 12 | 70 ± 18 a | 70 ± 11 b |